Anemia In Elderly Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Anemia In Elderly Market Size And Revenue Outlook Through 2030
The market for anemia in elderly has demonstrated strong expansion in recent years. It is projected to expand from $2.99 billion in 2025 to $3.26 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. Historically, this growth has been fueled by factors such as an aging population, the increasing prevalence of chronic diseases, the availability of oral iron supplements, the expansion of hospital-based anemia management, and rising awareness of nutritional deficiencies.
The market size for anemia in elderly individuals is projected to experience robust expansion over the coming years. This market is anticipated to reach $4.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This projected growth stems from factors such as an escalating demand for customized anemia treatments, the greater embrace of long-acting injectable medications, an increased emphasis on healthcare for the elderly, the broadening scope of outpatient anemia care, and advancements in diagnostic screening within elder care. Key trends expected during this period involve a rise in combination therapy methods, expanded utilization of injectable iron treatments, a heightened focus on early detection in older demographics, the proliferation of home-based treatment alternatives, and a stronger emphasis on addressing anemia linked to chronic diseases.
Get A Free Sample Report With In-Depth Market Insights:
Anemia In Elderly Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The expanding senior demographic is anticipated to stimulate the advancement of the anemia in the elderly market moving ahead. This demographic refers to the rising count and percentage of individuals aged 65 and above, either within a specific society or worldwide. The expansion of the elderly population stems from elements such as extended life expectancy, decreasing birth rates, and the maturation of substantial generational groups. An expanding elderly population leads to a higher occurrence of age-related and persistent health conditions, which are primary contributors to anemia among older adults. Consequently, this boosts the need for diagnosing, managing, and treating anemia, thereby spurring market expansion. For example, data from January 2024, provided by the Population Reference Bureau, a Kenya-based Nonprofit organization, indicates that the population of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, this demographic’s proportion of the total population is also forecast to increase from 17% to 23% within the identical timeframe. Thus, the increasing elderly population is propelling the expansion of the anemia in the elderly market.
Anemia In Elderly Market Segment Breakdown: Which Categories Lead On Revenue?
The anemia in elderly market covered in this report is segmented –
1) By Product Type: Tablets, Injectable
2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements
3) By Route Of Administration: Oral, Parenteral
4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy
Subsegments:
1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets
2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections
Anemia In Elderly Market Innovation Trends Shaping Future Development
Major companies engaged in the anemia in the elderly market are increasingly concentrating on technological advancements, particularly personalized therapies, with the aim of streamlining treatment processes, enhancing patient outcomes, minimizing side effects, and improving overall healthcare efficiency. Personalized therapies are medical interventions tailored to an individual patient’s specific characteristics. For example, in March 2024, Cadila Pharmaceuticals, an Indian pharmaceutical company, revealed the introduction of Redshot FCM, an innovative iron injection developed to manage iron deficiency anemia in patients intolerant to oral iron. This intravenous iron preparation effectively delivers sufficient iron and boasts an excellent safety profile. The injection incorporates an advanced Ferric Carboxymaltose formulation, which improves both iron delivery and absorption. Redshot FCM illustrates a commitment to bettering healthcare by devising personalized treatments that consider individual patient profiles, thereby achieving superior treatment results for iron deficiency anemia.
Anemia In Elderly Market Leading Players And Competitive Positioning
Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd
View The Full Anemia In Elderly Market Report:
Anemia In Elderly Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the anemia in elderly market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
